aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Deep 6 AI: Accelerating patient matching for clinical trials using advanced AI technology.
Deep 6 AI was founded with the mission to revolutionize patient recruitment for clinical trials through advanced artificial intelligence technology. The company's vision is to expedite and enhance the clinical trial process by efficiently matching patients to trials in minutes rather than months. Deep 6 AI offers a comprehensive platform that aids in trial design, site selection, patient recruitment, on-study monitoring, and post-study analysis. Their market focus is on healthcare providers, pharmaceutical companies, and clinical research organizations aiming to streamline and optimize clinical trials.
Notable affiliated individuals and investors include industry experts and venture capital firms specializing in healthcare technology. Deep 6 AI has achieved significant milestones, including the successful recruitment of over 23 million patients for various clinical trials. Their impact on the industry is profound, reducing the time and cost associated with patient matching and site selection, thereby accelerating the development of new treatments and therapies.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Patient Recruitment
Technology
AI, Machine Learning
Tags
Healthtech, Ai Operations
Model Types
SaaS
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Deep 6 AI founded?
Deep 6 AI was founded in 2015.
Where is Deep 6 AI’s headquarters located?
Deep 6 AI’s headquarters is located in Pasadena, CA, US.
When was Deep 6 AI’s last funding round?
Deep 6 AI’s most recent funding round was for $17M (USD) in November 2019.
How many employees does Deep 6 AI have?
Deep 6 AI has 68 employees as of Feb 4, 2024.
How much has Deep 6 AI raised to-date?
As of July 05, 2023, Deep 6 AI has raised a total of $17.6M (USD) since Nov 25, 2019.
Add Comparison
Total Raised to Date
$17.6M
USD
Last Update Nov 25, 2019
Last Deal Details
$17M
USD
Nov 25, 2019
Series A
Total Employees Over Time
68
As of Feb 2024
Deep 6 AI Address
1055 East Colorado Boulevard
suite 410
Pasadena,
California
91106
United States
TechCrunch
Triomics raises $15M Series A to automate cancer clinical trials matching
For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United...
May 9, 2024
Is this the right Deep 6 AI?
Help us improve our AI - Is this article for the right company?
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts